Patterns of progressive cortical thinning in dementia with Lewy bodies (DLB) 3 remains poorly understood. We examined spatiotemporal patterns of cortical thinning 4 and subcortical atrophy over 12 months in DLB (n=13), compared to Alzheimer's 5 disease (AD) (n=23) and healthy controls (HC) (n=33). Rates of temporal thinning in 6 DLB were relatively preserved compared to AD. Volumetric analyses subcortical 7 changes revealed that the AD group demonstrated significantly increased 8 hippocampal atrophy (-5.8%) relative to the HC (-1.7%; p<0.001) and DLB groups (-9 2.5%, p=0.006). Significant lateral ventricular expansion was also observed in AD 10 (8.9%) compared to HC (4.3%; p<0.001), and DLB (4.7%; p=0.008) at trend level. 11
INTRODUCTION 1 2
Dementia with Lewy bodies (DLB) is the second leading cause of degenerative 3 dementia in older people after Alzheimer's disease (AD), accounting for up to 15% of 4 cases confirmed at autopsy [1] [2] [3] . Because low sensitivity for the diagnosis for DLB 5 remains a problem [4] , there is a need for the development of reliable imaging 6 markers to help distinguish DLB from other subtypes of dementia. 7 8 Cortical thickness is increasingly recognized as a more precise parameter of age-9 associated decline in grey matter compared to the voxel-based morphometry (VBM) 10 technique [5, 6] . In a previous study, we found a greater extent of cortical thinning in 11 the AD group affecting predominantly temporo-parietal areas whereas DLB was 12 characterized with cortical thinning in posterior structures [7] . This finding is 13 consistent with a growing literature of reduced global atrophy in DLB compared to 14 AD [8], while the preservation of the medial temporal lobe in DLB has been 15 incorporated as a supportive feature in the revised criteria for the diagnosis of DLB 16 [9] . 17
As with our previous investigation, the majority of imaging studies in DLB has been 18 cross-sectional, and no study to date has investigated the longitudinal progression of 19 cortical thinning in DLB. To address this gap in the present literature, our aim in this 20 study was to compare the progression of cortical thickness over a 12-month period in 21 AD and DLB, and similarly aged healthy controls (HC). Based on earlier cross-22 sectional findings [8], we hypothesized that DLB would have significantly lower rates 23 of cortical thinning compared to AD, particularly in the temporal lobe. 24 optimally place the grey matter/white matter and grey matter/cerebrospinal fluid 1 (CSF) boundaries. The cortical thickness is calculated as the closest distance from the 2 grey/white matter boundary to the grey/CSF boundary at each vertex. All surface 3 models in our study were inspected for accuracy and manual corrections were 4 performed in the event of tissue misclassification / white matter errors. However, 3 5 subjects (2 AD, 1 DLB) still had extensive pial/white matter surface errors and were 6 excluded. The dataset for all subsequent analyses comprised of 33 HC, 23 AD, and 13 7 DLB. 8 9 Subsequently, for the longitudinal processing, an unbiased within-subject template 10 space [21] was created using robust, inverse consistent registration [22] . Several 11 processing steps, such as skull stripping, Talairach transformations, atlas registration, 12 as well as spherical surface maps and parcellations were then initialized with common 13 information from the within-subject template, significantly increasing reliability and 14 statistical power [23] . The cortical thickness maps were smoothed using a 15-mm full 15 width at half maximum Gaussian kernel to reduce local variations in the 16
measurements. 17
In addition, the following volumetric measures at both time-points were automatically 18 obtained using Freesurfer: total intracranial volume, lateral ventricles, and 7 19 subcortical structures including the thalamus, caudate, putamen, pallidum, 20 hippocampus, amygdala, and the nucleus accumbens. 21 22
Statistical analyses 23
Demographic and clinical measures MAK 7
Statistical analyses were performed with the STATA13 (http://www.stata.com/) 1 software. The distribution of continuous variables was tested for normality using the 2 Skewness-Kurtosis test and visual inspection of histograms. Parametric data were 3 assessed using either t-tests or analysis of variance (ANOVA) for continuous 4 variables. For non-parametric data, Kruskal-Wallis was used. χ 2 tests were used to 5 examine differences between categorical measures. For each test statistic, a two-tailed 6 probability value of < 0.05 was regarded as significant. 7 8
Cortical thickness comparisons 9
For each hemisphere, vertex-wise comparisons of percent change of cortical thickness 10 (PcCTh) among the subject groups were performed using the longitudinal two stage 11 general linear model in Freesurfer [23] . The PcCTh was the dependent factor and the 12 diagnostic group was the independent factor. Additionally, we examined the 13 correlations of PcCTh with cognitive decline (baseline scorefollow-up score. To 14 assess the involvement of PcCTH in disease severity, we assessed correlations with 15 change scores of the UPDRS. In all imaging analyses, age and gender were included 16 as nuisance covariates, and Family Wise Error (FWE) cluster-wise correction using 17
Monte Carlo simulations with 10,000 iterations were applied to correct for multiple-18
Longitudinal atrophy of subcortical structures 21
To reduce the number of comparisons, we derived a total volume for each structure by 22 combining the volumes from both hemispheres. For each subject, we first calculated 23 the absolute difference in volumes between both times [(volume follow-upvolume 24 baseline )], before dividing by the volume at baseline [(volume follow-upvolume baseline ) / 25 volume baseline ] to quantify the amount of atrophy with respect to baseline, before 1 multiplying by 100 to derive a percentage change score: [(volume follow-upvolume 2 baseline ) / volume baseline ] * 100%. Subsequently, group differences in percentage change 3 of subcortical volumes were tested with analysis of covariance (ANCOVA) 4 controlling for age, gender, and the average of total intracranial volumes at both time-5 points. Post-hoc Tukey-Kramer pairwise comparisons were subsequently tested 6 between each group. 7 8 3. Results 9
Subject characteristics 10
The demographic and clinical data for dementia and control subjects are summarized 11
in Table 1 . Subject groups were well matched for age, gender, and educational level, 12
and there was no difference in inter-scan intervals among all subject groups (p=0.21). 13
As expected, the DLB group had significantly higher UPDRS scores than the AD and 14 HC groups at both time-points. Functional ability (BADLS) was similar in DLB and 15 AD (p=0.23). Disease duration was comparable in both DLB (52.2 months) and AD 16 (51.8 months; p=0.96), and the proportion of subjects on cholinesterase inhibitors was 17 also similar (p=0.23). There were no significant differences in changes of NPI 18 
Comparisons of longitudinal cortical thinning: DLB vs HC 20
There were no significant differences in PcCTh in any regional areas between the 21 DLB and HC groups. 22
23

Clinical and cognitive associations of cortical thinning 24
The anatomical results for the vertex-wise correlational analyses are displayed in 25 relative to the HC (-1.7%; p<0.001) and DLB groups (-2.5%, p=0.006). Significant 14 lateral ventricular expansion was also observed in AD (8.9%) compared to HC (4.3%; 15 p<0.001), and DLB (4.7%; p=0.008) at trend level. There was no significant 16 difference in subcortical atrophy and ventricular expansion between DLB and HC. 17 18
Discussion 19
Previous longitudinal studies in DLB have focused on the assessment of global brain 20 measures such as whole brain atrophy rates, yielding somewhat conflicting results. 21 O'Brien and colleagues found no significant differences in whole brain atrophy rates 22 between AD and DLB [25] . In contrast, another study with pathological confirmation 23 of diagnosis revealed significantly greater global atrophy rates in AD compared to 24 DLB [26]. To our knowledge, this is the first study to evaluate the topographical 25 differences in the progression of cortical thinning between DLB and AD. The main 1 findings are: (i) DLB and AD are characterized by distinct spatial and temporal 2 patterns of cortical thinning. Consistent with our a priori hypothesis, the temporal 3 lobe showed significantly greater cortical thinning in AD compared to DLB over the 4 follow-up period; (ii) regional cortical thinning over time was correlated with 5 cognitive decline in both AD and DLB groups; (iii) significantly greater loss of 6 hippocampal volume and lateral ventricular expansion over 1 year was also observed 7 in the AD group. suggests that alpha-syunclein is not a direct causative factor of neurodegeneration. 24
Rather, it triggers a series of secondary molecular processes that eventually leads to 25 neuroinflammation, disruption of neurotransmitters, and eventually cell loss [27, 28] . 1 Consistent with this view, we found no differences in the rates of regional cortical 2 thinning between DLB and HC over 12 months. Although it is possible that our 3 negative finding might represent a Type-II error due to the relatively small sample 4 size of DLB (n=13) and short duration of follow-up (1 year), corroborative evidence 5 have come from previous studies. A larger study has found similar global and integrating SPECT and MRI in conjunction). In terms of improving accuracy in 5 differential diagnosis, MRI striatal volumetric data have been combined with occipital 6 perfusion SPECT to distinguish subjects with mild DLB from subjects with mild AD 7 with a high degree of sensitivity and specificity [34] . 8 9
The clinical implications of cortical thinning in DLB are still poorly understood. Our 10 correlational analyses of the UPDRS change scores among the DLB subjects revealed 11 a significant association between increased thinning in the superior parietal cortex and 12 greater motor deterioration. Our findings are in accord with recent VBM studies 13 demonstrating significant atrophy of the parietal cortex in PD subjects presenting with 14 freezing of gait compared to PD subjects without freezing symptoms [35, 36] . In 15 addition, white matter hyperintensities in the parietal lobe has been linked to impaired 16 balance and postural support [37] . Taken together, these findings fits within the 17 framework that the superior parietal lobe is part of the motor system involved in 18 sensorimotor integration. 19
The frontal lobe was also involved with cognitive decline in the DLB group. 20
Increased thinning in the superior frontal regions was associated with greater decline 21 in MMSE, an index of global cognition. In addition, increased thinning in the left 22 rostral middle frontal regions was correlated with both the orientation and language 23 components of the CAMCOG assessment. Similarly, reductions in prefrontal volumes 24 have been correlated with attentional deficits [38] . Despite the small sample size in our study, the potential of the frontal lobe as a plausible biomarker for cognitive 1 impairment in DLB should be established further in a larger cohort of DLB subjects. 2 3 Increased cortical thinning over 1 year in AD relative to HC was found in the 4 temporo-parietal areas extending to the frontal regions. Our results are thus in 5 agreement with earlier studies demonstrating that AD is associated with progressive 6 loss of whole brain volumes, particularly in the medial temporal structures [25] . 7
Increased rates of cortical thinning were also found in the precuneus and the isthmus 8 of the cingulate gyrus. Both structures are involved in the default mode network, 9 which has been found to be impaired in AD [39] . Indeed, the precuneus has been to HC and DLB also agrees with previous studies [42] . 19
20
The major strengths of the study include the comprehensive neuropsychological 21 assessment and a well-characterized group of probable DLB and AD patients. In 22 addition, all the groups were matched for age, gender, and educational level. The 23 longitudinal design, a rarity in the DLB imaging literature, allowed us to address 24 unanswered questions related to the progression and clinical implications of cortical 25 thinning in Lewy body dementia. Some potential limitations of this study include the 1 lack of neuropathological verification of AD and DLB, as subject groups were based 2 on clinical diagnosis, though this is an inherent limitation of all ante-mortem imaging 3 studies. Furthermore, we have previously demonstrated good agreement between 4 clinical and pathological diagnosis using the consensus clinical diagnostic method 5 adopted here [43] . Attrition of subjects is also a common drawback in longitudinal 6 studies. Less than half (n=14) of the originally recruited DLB subjects (n=35) 7 returned for a follow-up assessment due to disease progression including 9 deaths. 8 However, they did not differ from those who were unable to complete the 12-month 9 assessment (n=21) in age or measures of global cognition, neuropsychiatric features 10 or motor parkinsonism (Table 2) . Finally, to minimize the number of comparisons 11 between the DLB, AD and HC groups, we have summed the left and right 12 hemispheric measures of each subcortical structure. Although there is no evidence to 13 indicate systematic laterality of subcortical changes in AD and DLB, our combined 14 volumes for each structure might have resulted in a loss of potential information about 15 asymmetrical disease-related changes. 16 17
Conclusion 18
In accordance with our hypothesis, faster thinning over 1 year was found in the 19 temporal lobe in AD relative to DLB. Besides validating the inclusion of the medial 20 temporal lobe as a supportive biomarker in the revised diagnostic criteria for DLB, 21 our findings also highlight the clinical utility of longitudinal cortical thinning as a 22 complementary imaging marker to differentiate DLB from AD. Greater cortical 23 thinning could exert deleterious effects on global cognitive decline and was associated 24 with increasing motor severity in DLB. However, our finding of similar rates of 25 Michael Firbank designed the imaging protocol, assisted with the interpretation of the 20 results, and reviewed the manuscript. 21
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